Kiley Juergens Wealth Management’s AbbVie ABBV Stock Holding History

Kiley Juergens Wealth Management’s Portfolio ABBV Stock Details ABBV Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$1.59M	Buy	+7,295	New	+$1.62M	0.28%	65
2023 Q4	–	Sell	-10,030	Closed	-$1.5M	–	66
2023 Q3	$1.5M	Sell	10,030 -1,344	-12%	-$197K	0.54%	36
2023 Q2	$1.53M	Sell	11,374 -2,395	-17%	-$351K	0.53%	35
2023 Q1	$2.19M	Buy	13,769 +144	+1%	+$22K	0.82%	31
2022 Q4	$2.2M	Sell	13,625 -91	-0.7%	-$14K	0.92%	26
2022 Q3	$1.84M	Buy	13,716 +10	+0.1%	+$1.44K	0.87%	28
2022 Q2	$2.1M	Buy	+13,706	New	+$2.09M	0.99%	24
2022 Q1	–	Sell	-13,970	Closed	-$1.89M	–	53
2021 Q4	$1.89M	Buy	13,970 +1,904	+16%	+$225K	0.72%	28
2021 Q3	$1.3M	Buy	+12,066	New	+$1.38M	0.57%	34
2018 Q4	–	Sell	-1,761	Closed	-$166K	–	41
2018 Q3	$166K	Buy	1,761 +721	+69%	+$68.4K	0.12%	113
2018 Q2	$96K	Buy	+1,040	New	+$102K	0.09%	137
2018 Q1	–	Sell	-1,055	Closed	-$102K	–	84
2017 Q4	$102K	Buy	+1,055	New	+$99.4K	0.09%	128

Other funds holding ABBV

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

VPM

Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Kiley Juergens Wealth Management's ABBV Position: Q1 2026 in Review

Kiley Juergens Wealth Management opened a new position in AbbVie (ABBV) in Q1 2026: 7,295 shares worth $1.59M. The stake represents 0.28% of the portfolio and ranks #65 among its holdings. This is a return to the name: Kiley Juergens Wealth Management previously reported a position in ABBV as recently as Q3 2023.

Kiley Juergens Wealth Management first reported a position in ABBV in Q4 2017 and has held it in 12 quarters since. The position peaked at $2.2M in Q4 2022. 4,079 funds tracked by Wall St. Rank hold ABBV as of Q1 2026.

Kiley Juergens Wealth Management held 7,295 shares of AbbVie worth $1.59M as of Q1 2026.
AbbVie was a new Kiley Juergens Wealth Management position in Q1 2026.
AbbVie made up 0.28% of Kiley Juergens Wealth Management's portfolio in Q1 2026, its #65 holding.
Kiley Juergens Wealth Management first reported a position in AbbVie in Q4 2017 and has held it in 12 quarters since.
Kiley Juergens Wealth Management's AbbVie position peaked at $2.2M in Q4 2022.
4,079 funds tracked by Wall St. Rank held AbbVie as of Q1 2026.

Based on Kiley Juergens Wealth Management's 13F filing for Q1 2026, filed 28 Apr 2026.